Redeye considers Polygiene’s Q4'25 figures to be soft, missing our expectations by 18% on top-line, primarily driven by lower Polygiene sales. Subsequently, EBITDA missed our expectations, driven by the lower sales and one-time CEO shift costs impacting the quarter. We expect to make downward estimate adjustments for 2026 while remaining positive to the long-term outlook.
LÄS MER
